Related Experiment Video
Updated: Mar 23, 2026
09:36
Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
Published on: June 28, 2019
10.8K
RBD and Neurodegenerative Diseases.
Haiyang Jiang1, Jinsha Huang1, Yan Shen1
1Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Road, Wuhan, 430022, Hubei, China.
Molecular Neurobiology
|April 2, 2016
Summary
Rapid eye movement (REM) sleep behavior disorder (RBD) involves acting out dreams and may indicate future neurodegenerative diseases. Early identification of RBD is crucial for potential disease prediction and management.
Area of Science:
- Neurology
- Sleep Medicine
- Neuroscience
Background:
- Rapid eye movement (REM) sleep behavior disorder (RBD) is characterized by dream enactment during REM sleep, often with violent or aggressive content.
- While population prevalence is low (0.38-2.01%), RBD is significantly more common in patients with neurodegenerative diseases, particularly synucleinopathies.
Purpose of the Study:
- To review the clinical and polysomnographic (PSG) features of RBD.
- To explore the pathophysiology and therapeutic options for RBD.
- To emphasize the correlation between RBD and neurodegenerative diseases, highlighting RBD's potential as an early diagnostic marker.
Main Methods:
- Literature review summarizing existing research on RBD.
- Analysis of clinical and PSG data related to RBD.
- Focus on the link between RBD and synucleinopathies and other neurodegenerative conditions.
Main Results:
- RBD can precede the onset of synucleinopathies by many years.
- RBD serves as a significant early warning sign for neurodegenerative diseases.
- Current pharmaceutical treatments for RBD include clonazepam, melatonin, and pramipexole.
Conclusions:
- RBD is strongly associated with underlying neurodegenerative processes.
- RBD's role as an early marker for neurodegenerative diseases is of critical importance.
- Further research into the mechanisms and early detection of RBD is warranted.
Related Concept Videos
01:15Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
01:37Neural Regulation
44.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.6K
01:15REM Sleep Behavior Disorder
2.4K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
2.4K
01:28Disorders of the Nervous Tissue
3.0K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.0K
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K